A detailed history of Elmwood Wealth Management, Inc. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Elmwood Wealth Management, Inc. holds 2,364,240 shares of CRBU stock, worth $6.81 Million. This represents 5.56% of its overall portfolio holdings.

Number of Shares
2,364,240
Previous 2,364,260 0.0%
Holding current value
$6.81 Million
Previous $13.5 Million 10.3%
% of portfolio
5.56%
Previous 9.8%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$4.82 - $8.26 $96 - $165
-20 Reduced -0.0%
2,364,240 $12.2 Million
Q4 2023

Jan 30, 2024

SELL
$3.58 - $6.25 $554 - $968
-155 Reduced 0.01%
2,364,260 $13.5 Million
Q2 2023

Aug 10, 2023

BUY
$4.04 - $5.47 $707 - $957
175 Added 0.01%
2,364,415 $10 Million
Q3 2022

Nov 14, 2022

BUY
$5.34 - $12.79 $12.6 Million - $30.2 Million
2,364,240 New
2,364,240 $24.9 Million

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $175M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Elmwood Wealth Management, Inc. Portfolio

Follow Elmwood Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elmwood Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Elmwood Wealth Management, Inc. with notifications on news.